Prolyl hydroxylase inhibitor desidustat improves stroke outcomes via enhancing efferocytosis in mice with chronic kidney disease

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 91a21d0bfe26644d-LAX IP: 47.97.18.252 UTC time: 2025-03-02T16:01:34+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4

Comments (0)

No login
gif